CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Chief Commercial Officer bought 6,493 shares at $1.54 ($9,999)
- 4 Open-market buy CFO and Chief Corp. Deve. Off. bought 20,000 shares at $1.53 ($30,600)
- 4 Open-market buy Chief Medical Officer bought 7,500 shares at $1.55 ($11,625)
- 4 Open-market buy Director bought 50,000 shares at $1.32 ($66,000)
- 4 Open-market buy Director bought 6,000 shares at $1.29 ($7,740)
- 4 Open-market buy Director bought 16,000 shares at $1.26 ($20,160)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 26 · 506 filings